MedCity News

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

Changes in Nurse Staffing Answer Clinician Demands

The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.

By Tomasz Rezik

Events

Check Out the Future of Medtech: A Preview of Device and Diagnostics INVEST Pitch Perfect Finalists

Finalists in the Pitch Perfect contest at INVEST, scheduled for May 20-21 in Chicago at the Willis Tower, span medtech for asthma, diabetic neuropathy, Parkinson's disease, and more. Register today!

By Stephanie Baum

MedCity Influencers

The Workforce is Suffering from Chronic Back Pain — It’s Time for a New Approach

While high-acuity options must remain for those that need stronger interventions, millions more could be benefiting from access to low-acuity or minimal interventions.

By Joseph Brence

Latest News

Health Tech

Talkspace Introduces AI-Powered Personalized Podcasts

Talkspace introduced Talkcast on Monday, an AI-powered feature that allows therapists to generate personalized podcast episodes for clients.

By Marissa Plescia

BioPharma, Pharma

Vertex Cell Therapy Misses in the Clinic, But It Has Other Shots on the Type 1 Diabetes Goal

Vertex Pharmaceuticals is stopping development of VX-264, an experimental cell therapy/medical device treatment for type 1 diabetes, after an early look at Phase 1/2 data fell short of efficacy goals. This program came from a $950 million acquisition in 2019 that marked Vertex’s entry into type 1 diabetes.

By Frank Vinluan

MedCity Influencers

How Real-World Data Can Support Label Extension And Safer Use Of Novel Therapies

Engaging in data sharing, observational cohort research, and deeper analysis of available data to yield further insights can drive improved results for patients, making label and cohort extension faster and more robust.

By Jenna Phillips

Two Chairs Expands Mental Health Services to 19 More States

Two Chairs, which offers hybrid behavioral health care, expanded its presence from three states to 22 states. This expansion gives millions of people access to therapy services, as Two Chairs’ services are now available to 75% of the U.S. population.

By Katie Adams

Providers

What’s Private Equity’s Impact on Intellectual and Developmental Disability Services?

A new report from the Private Equity Stakeholder Project reveals that private equity firms have been increasingly acquiring intellectual and developmental disability providers and implementing cost-cutting strategies that reduce care quality.

By Marissa Plescia

Take the 2025 Benefit Consultant Sentiment Index Survey

If you’re helping clients navigate big changes—from the surge in GLP-1 demand to AI to the growing pressure to demonstrate ROI – we want your thoughts.

By MedCity News

Devices & Diagnostics, BioPharma

PCR Comes to the Home With FDA Authorization of Visby’s OTC Sexual Health Test

The FDA granted marketing authorization to a Visby Medical at-home PCR test for three common sexually transmitted infections. The Visby test yields results in about 30 minutes.

By Frank Vinluan

MedCity Influencers

The Case for 340B Done Right

It’s critical that healthcare organizations delivering on the program’s promise not be torpedoed by the “bad actors”

By Clifford W. Knights

Tackling Rising Drug Costs and Growing Popularity of GLP-1’s

See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.

By Quantum Health and MedCity News

MedCity Influencers

Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional Settings

To reduce overdose rates in the U.S., leaders must recognize the impact of medication-assisted treatment in correctional facilities.

By Jeffrey Alvarez

Payers

Report: How Medicaid/SNAP Cuts Could Affect the Economy

Medicaid and SNAP cuts could lead to 1 million jobs lost in just 2026, according to a new report from the Commonwealth Fund and the George Washington University Milken Institute School of Public Health.

By Marissa Plescia

Hospitals, Health Tech Providers,

Most Healthcare Providers Remain Highly Vulnerable to Ransomware Attacks

About 90% of healthcare organizations are insecurely connected to the internet and running systems vulnerable to exploitation by ransomware gangs, according to new research. It also found that 78% of providers have made ransomware payments of $500,000 or more.

By Katie Adams

BioPharma, Pharma

Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1s

Novo Nordisk gets global rights to Lexicon Pharmaceuticals’ LX9851, an oral small molecule with a first-in-class approach to sparking weight loss. The licensing agreement comes months after Lexicon reported encouraging preclinical data from tests of LX9851 in combination with semaglutide, the main ingredient in Novo Nordisk’s Wegovy.

By Frank Vinluan

MedCity Influencers

How Community Health Programs are Reducing 911 Calls and Helping Patients Before Emergencies

By focusing on prevention, collaboration, and data-driven innovation, community health programs are ensuring resources are used more effectively and patient care is proactive rather than reactive.

By Joe Graw

MedCity Influencers

Bridging the AI Gap in Local Health: Practical Steps for Adoption

By prioritizing staff education, starting small with practical applications, and establishing clear guidelines, local health departments can lay the foundation for sustainable AI adoption. This approach ultimately enhances efficiency, improves health outcomes, and ensures cost-effective care for the communities they serve.

By John Auerbach and Eddie Kirkland

Health Tech, Payers

Startup Launches To Offer Payers an AI-Powered Contact Center Platform

TrampolineAI launched out of Redesign Health to help health plans with their contact centers.

By Marissa Plescia

BioPharma, Pharma

Rare Metabolic Disease That Leads to Childhood Obesity Gets Its First FDA-Approved Drug

Soleno Therapeutics’ Vykat XR is now FDA approved for treating hyperphagia, or excessive hunger, in patients with Prader-Willi syndrome. The once-daily pill is the first approved therapy for this rare disease, a leading cause of childhood obesity.

By Frank Vinluan